A comparison of short-term therapeutic efficacy between infliximab and tacrolimus for moderate to severe ulcerative colitis

• Autores principales: Yamagami Hirokazu (Autor), Nishida Yu (Autor), Nagami Yasuaki (Autor), Hosomi Shuhei (Autor), Yukawa Tomomi (Autor), Otani Koji (Autor), Tanaka Fumio (Autor), Taira Koichi (Autor), Kamata Noriko (Autor), Tanigawa Tetsuya (Autor), Shiba Masatsugu (Autor), Watanabe Toshio (Autor), Fujiwara Yasuhiro (Autor)
• Formato: Libro
• Publicado: Sciendo, 2017-09-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Introduction. Both infliximab (IFX) and tacrolimus (Tac) are effective for inducing clinical remission in patients with ulcerative colitis (UC). However, no randomized study has addressed the relative efficacies of IFX and Tac for patients with moderate to severe UC. This study aimed to conduct a re...